Impact of pretreatment body mass index on the survival of head and neck cancer patients.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 38269627.
- Also identified by DOI 10.1002/hed.27659 and PMC identifier 11227405.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Differences in pretreatment body mass index (BMI) have been associated with survival in squamous cell carcinoma of head and neck (SCCHN). We examined effects of BMI on survival in SCCHN patients after stratifying patients by tumor human papillomavirus (HPV) status and subsite. Totally 2204 SCCHN patients in a prospective study were included in this secondary analysis. Multivariable Cox models were used to evaluate associations between pretreatment BMI and overall survival, disease-specific survival, and disease-free survival. BMI was significantly higher among patients with HPV-positive tumors than HPV-negative tumors. BMI >25 kg/m<sup>2</sup> was associated with improved survival, while BMI <18.5 kg/m<sup>2</sup> was associated with reduced survival, particularly in patients with HPV-positive oropharyngeal cancer tumors. This exploratory analysis suggests that pretreatment BMI could be an independent prognostic factor of survival outcomes in SCCHN patients, particularly in patients with HPV-positive oropharyngeal cancer tumors. Further prospective investigations are warranted.
Medical subject headings
- Body Mass Index
- Head and Neck Neoplasms
- Squamous Cell Carcinoma of Head and Neck